Patents Assigned to Rose Pharma LLC
  • STABLE LIQUID FORMULATIONS OF GLUCAGON-LIKE PEPTIDE 1 OR ANALOGUES THEREOF
    Publication number: 20210283226
    Abstract: Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.
    Type: Application
    Filed: May 28, 2021
    Publication date: September 16, 2021
    Applicant: Rose Pharma LLC
    Inventors: Andrea HAWE, Eva KEILHAUER, Olimpia POPKO, Enda KENNY, Richard WARBURG
  • Stable liquid formulations of glucagon-like peptide 1 or analogues thereof
    Patent number: 11058748
    Abstract: Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: July 13, 2021
    Assignee: Rose Pharma LLC
    Inventors: Andrea Hawe, Eva Keilhauer, Olimpia Popko, Enda Kenny, Richard Warburg
  • STABLE LIQUID FORMULATIONS OF GLUCAGON-LIKE PEPTIDE 1 OR ANALOGUES THEREOF
    Publication number: 20210169987
    Abstract: Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.
    Type: Application
    Filed: December 2, 2020
    Publication date: June 10, 2021
    Applicant: Rose Pharma LLC
    Inventors: Andrea HAWE, Eva KEILHAUER, Olimpia POPKO, Enda KENNY, Richard WARBURG